<?xml version="1.0" encoding="UTF-8"?>
<!-- This is a template for a FHIR resource, and needs items (marked with "${}") replacing to make a real instance -->
<!-- The resulting instance is a Bundle of Bundles, each of which is a document (having a Composition, and supporting resources) -->
<!-- 2020-02-22 -->
<!-- This is for FHIR version R5 Preview 2 (May 2020) -->
<Bundle xmlns="http://hl7.org/fhir">
	<type value="collection"/>
	<!-- Repeat at this level per document -->
	<entry>
		<fullUrl value="${instance.bundle[n].fullUrlUrnUuid}"/>
		<!-- Top level of each document is a also FHIR Bundle, of type "document"
		 see http://hl7.org/fhir/documents.html, http://hl7.org/fhir/bundle.html
	 	 All the other resources for this document are within this. -->
		<resource>
            <Bundle>
            	<!-- When PUTing, some servers mandate an id here to match the existing id -->
            	<id value="${instance.bundle[n].idUuid}"/>
				<!-- document bundles must have an identifier (bdl-9) -->
				<identifier>
					<!-- possibly different identifier types may be needed here -->
					<system value="http://ema.europa.eu/fhir/identifier/documentid"/>
					<value value="${instance.bundle[n].Identifier}"/>
				</identifier>
				<!-- fixed code -->
				<type value="document" /> 
            	<!-- document bundles must have a date (bdl-10) -->
            	<timestamp value="${document[n].authoringDateTime}"/>
				<!-- a repeating set of entry elements, each with a FHIR resource inside -->
				<entry>
					<!-- fullUrl is mandatory for each entry in document Bundle. It is a random uuid. http://build.fhir.org/bundle.html#bundle-unique -->
					<fullUrl value="${instance.bundle[n].compositionFullUrlUuid}"/>
					<resource>
						<!-- the first resource must be Composition (bdl-11) -->
						<!-- This is the overall document structure. -->
						<!-- see definition http://hl7.org/fhir/composition.html, and similar for other resources -->
                        <Composition>
                        	<!-- images if requied within html text of this document -->
							
							<status value="final"/>
							<!-- document type -->
							<type>
								<coding>
									<system value="http://spor.ema.europa.eu/v1/lists/100000155531"/>
									<code value="${document[n].documentTypeCode}"/>
									<display value="${document[n].documentTypeDisplay}"/>
								</coding>
							</type>
							<subject>
								<!-- links to the List resource in this bundle - local url format -->
								<reference value="List/${instance.bundle[n].listId}"/> <!-- local url format -->
								<!--reference value="${instance.bundle[n].listUuid}"/--> <!-- uuid url format. Possible alternate format may be neeed -->
							</subject>
                        	<!-- mandatory date of the document -->
                        	<date value="${document[n].authoringDate}"/>
							<author>
								<identifier>
									<system value="http://spor.ema.europa.eu/v1/locations" />
									<value value="${document[n].organizationOMSCode}" />
								</identifier>
							</author>
                        	<title value="${document[n].title}"/>
							<relatesTo>
								<code value="appends"/>
								<targetReference>
									<!-- reference to another Composition -->
									<reference value="${document[n].relatesTo}"/>
								</targetReference>
							</relatesTo>
							<!-- main sections of the document, to follow the QRD template -->
	               			
<section>
	
		
			<title value="Annex II"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p align="center" class="No-numheading3Agency" style="margin:0in;text-align:center; page-break-after:auto"><span lang="EN-GB" style='font-family:"Times New Roman",serif; text-transform:uppercase'>Annex II</span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span></p>
			</div>
		</text>
		

		
    	    

			    
		               
<section>
			<title value="A.      MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><b><span lang="EN-GB">A.      MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE </span></b></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><b><span lang="EN-GB">B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p><p class="TitleB"><span lang="EN-GB" style="text-transform:none"> </span></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="C.      OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><b><span lang="EN-GB">C.      OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p><p class="TitleB"><span lang="EN-GB" style="text-transform:none;font-weight:normal"> </span></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="D.      CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><b><span lang="EN-GB">D.      CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB"> </span></p><b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman Bold"; text-transform:uppercase'><br clear="all" style="page-break-before:always"/> </span></b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman Bold"; text-transform:uppercase'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
	
		

		
    	    

			    
		               
<section>
			<title value="A.      MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="TitleB"><span lang="EN-GB">A.      MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE</span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Name and address of the manufacturer(s) responsible for batch release"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"><u><span lang="EN-GB">Name and address of the manufacturer(s) responsible for batch release</span></u></p><p class="MsoNormal" style="line-height:normal"><u><span lang="EN-GB"><span style="text-decoration:none"> </span></span></u></p><p class="MsoNormal"><span lang="EN-GB">Almac Pharma Services (Ireland) Limited</span></p><p class="MsoNormal"><span lang="EN-GB">Finnabair Industrial Estate</span></p><p class="MsoNormal"><span lang="EN-GB">Dundalk</span></p><p class="MsoNormal"><span lang="EN-GB">Co. Louth</span></p><p class="MsoNormal"><span lang="EN-GB">A91 P9KD</span></p><p class="MsoNormal"><span lang="EN-GB">Ireland</span></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB"> </span></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Almac Pharma Services Ltd.</span></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Seagoe Industrial Estate</span></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Craigavon</span></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Co. Armagh BT63 5UA</span></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">United Kingdom</span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.</span></p><p class="NormalAgency"><span lang="EN-GB" style='font-size:11.0pt;font-family: "Times New Roman",serif'> </span></p><p class="NormalAgency"><span lang="EN-GB" style='font-size:11.0pt;font-family: "Times New Roman",serif'> </span></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="TitleB"><span lang="EN-GB">B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></p><p class="NormalAgency"><span lang="EN-GB" style='font-size:11.0pt;font-family: "Times New Roman",serif'> </span></p><p class="NormalAgency"><span lang="EN-GB" style='font-size:11.0pt;font-family: "Times New Roman",serif'>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</span></p><p class="NormalAgency"><span lang="EN-GB" style='font-size:11.0pt;font-family: "Times New Roman",serif'> </span></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="C.      Other conditions and requirements of the Marketing Authorisation"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="TitleB"><span lang="EN-GB">C.      Other conditions and requirements of the Marketing Authorisation</span></p><p class="MsoNormal"><span lang="EN-GB"> </span></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="·         Periodic safety update reports (PSURs)"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;line-height: normal"><span lang="EN-GB" style="font-family:Symbol">·<span style='font:7.0pt "Times New Roman"'> </span></span><b><span lang="EN-GB">Periodic safety update reports (PSURs)</span></b></p><p class="MsoNormal" style="margin-right:28.35pt;line-height:normal"><span lang="EN-GB"> </span></p><p class="MsoNormal" style="margin-right:-1.85pt;line-height:normal"><span lang="EN-GB">The requirements for submission of PSURs for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.</span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span></p><p class="NormalAgency"><span lang="EN-GB" style='font-size:11.0pt;font-family: "Times New Roman",serif'> </span></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="D.      Conditions or restrictions with regard to the safe and effective use of the medicinal product"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="TitleB"><span lang="EN-GB">D.      Conditions or restrictions with regard to the safe and effective use of the medicinal product</span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="·         Risk management plan (RMP)"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="NormalAgency" style="margin-left:.25in;text-indent:-.25in"><span lang="EN-GB" style="font-size:11.0pt;font-family:Symbol">·<span style='font:7.0pt "Times New Roman"'> </span></span><b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>Risk management plan (RMP)</span></b></p><p class="NormalAgency"><u><span lang="EN-GB" style='font-size:11.0pt;font-family: "Times New Roman",serif'><span style="text-decoration:none"> </span></span></u></p><p class="MsoNormal" style="margin-right:28.35pt;line-height:normal"><span lang="EN-GB">The marketing authorisation holder (MAH) shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the marketing authorisation and any agreed subsequent updates of the RMP.</span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span></p><p class="MsoNormal" style="margin-right:-.05pt;line-height:normal"><span lang="EN-GB">An updated RMP should be submitted:</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;line-height: normal"><span lang="EN-GB" style="font-family:Symbol">·<span style='font:7.0pt "Times New Roman"'> </span></span><span lang="EN-GB">At the request of the European Medicines Agency;</span></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;line-height: normal"><span lang="EN-GB" style="font-family:Symbol">·<span style='font:7.0pt "Times New Roman"'> </span></span><span lang="EN-GB">Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.</span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'> </span></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="·         Obligation to conduct post-authorisation measures"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="NormalAgency" style="margin-left:.25in;text-indent:-.25in"><span lang="EN-GB" style="font-size:11.0pt;font-family:Symbol">·<span style='font:7.0pt "Times New Roman"'> </span></span><b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>Obligation to conduct post-authorisation measures</span></b></p><p class="NormalAgency"><span lang="EN-GB" style='font-family:"Times New Roman",serif; layout-grid-mode:line'> </span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal;page-break-after: avoid"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif; layout-grid-mode:line'>The MAH shall complete, within the stated timeframe, the below measures:</span></p><p class="BodytextAgency" style="margin-bottom:0in;line-height:normal;page-break-after: avoid"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif; layout-grid-mode:line'> </span></p><table border="1" cellpadding="0" cellspacing="0" class="TableGrid1" style="border-collapse:  collapse;border:none"> <tr> <td style="width:3.75in;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p class="BodytextAgency" style="margin-bottom:0in;line-height:normal;   page-break-after:avoid"><b><span lang="EN-GB" style='font-size:11.0pt;   font-family:"Times New Roman",serif;layout-grid-mode:line'>Description</span></b></p> </td> <td style="width:189.65pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="253"> <p class="BodytextAgency" style="margin-bottom:0in;line-height:normal;   page-break-after:avoid"><b><span lang="EN-GB" style='font-size:11.0pt;   font-family:"Times New Roman",serif;layout-grid-mode:line'>Due date</span></b></p> </td> </tr> <tr> <td style="width:3.75in;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Long-term effectiveness study to compare disease progression among   children with CF who have a specified CFTR gating mutation and are aged 2   through 5 years at the time of Kalydeco treatment initiation versus disease progression   among concurrent matched cohort of children with CF who have never received   Kalydeco treatment.</span></p> </td> <td style="width:189.65pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="253"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SV">Interim analysis 1: December 2017</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SV"> </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SV">Interim analysis 2: December 2019</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SV"> </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Interim analysis 3: December 2021</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB"> </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Final report: December 2023</span></p> </td> </tr> </table><p class="NormalAgency"><span lang="EN-GB" style='font-size:11.0pt;font-family: "Times New Roman",serif'> </span></p><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
	
</section>
							<!-- sections can repeat as necessary -->
						</Composition>
					</resource>
				</entry>
				<!-- an entry that is a list of PMS Product references -->
				<entry>
					<fullUrl value="${instance.bundle[n].listFullUrlUuid}"/>
					<resource>
                        <List>
							<!-- any id will do -->
                        	<id value="${instance.bundle[n].listId}"/>
							<status value="current"/>
							<mode value="working"/>
							<entry>
								<item>
									<reference value="${instance.product[n].url}"/>
									<display value="${instance.product[n].name}"/>
								</item>
							</entry>
						</List>
					</resource>
				</entry>
			</Bundle>
		</resource>
	</entry>
</Bundle>